| Hepatocyte nuclear factor 4α suppresses the development of hepatocellular carcinoma BF Ning, J Ding, C Yin, W Zhong, K Wu, X Zeng, W Yang, YX Chen, ... Cancer research 70 (19), 7640-7651, 2010 | 259 | 2010 |
| Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes X Deng, X Zhang, W Li, RX Feng, LU Li, GR Yi, XN Zhang, C Yin, HY Yu, ... Cell stem cell 23 (1), 114-122. e3, 2018 | 254 | 2018 |
| Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor‐4α gene C Yin, Y Lin, X Zhang, YX Chen, X Zeng, HY Yue, JL Hou, X Deng, ... Hepatology 48 (5), 1528-1539, 2008 | 245 | 2008 |
| Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats HY Yue, C Yin, JL Hou, X Zeng, YX Chen, W Zhong, PF Hu, X Deng, ... Gut 59 (2), 236-246, 2010 | 172 | 2010 |
| Recombinant adenovirus carrying the hepatocyte nuclear factor‐1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice X Zeng, Y Lin, C Yin, X Zhang, BF Ning, Q Zhang, JP Zhang, L Qiu, ... Hepatology 54 (6), 2036-2047, 2011 | 102 | 2011 |
| Hepatocyte nuclear factor 4α‐nuclear factor‐κB feedback circuit modulates liver cancer progression BF Ning, J Ding, J Liu, C Yin, WP Xu, WM Cong, Q Zhang, F Chen, T Han, ... Hepatology 60 (5), 1607-1619, 2014 | 100 | 2014 |
| Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte‐like cells X Deng, YX Chen, X Zhang, JP Zhang, C Yin, HY Yue, Y Lin, ZG Han, ... Journal of cellular physiology 217 (1), 138-144, 2008 | 92 | 2008 |
| Hepatocyte nuclear factor‐4α reverses malignancy of hepatocellular carcinoma through regulating miR‐134 in the DLK1‐DIO3 region C Yin, PQ Wang, WP Xu, Y Yang, Q Zhang, BF Ning, PP Zhang, WP Zhou, ... Hepatology 58 (6), 1964-1976, 2013 | 91 | 2013 |
| Perturbation of MicroRNA‐370/Lin‐28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma WP Xu, M Yi, QQ Li, WP Zhou, WM Cong, Y Yang, BF Ning, C Yin, ... Hepatology 58 (6), 1977-1991, 2013 | 79 | 2013 |
| SHP-1 acts as a tumor suppressor in hepatocarcinogenesis and HCC progression LZ Wen, K Ding, ZR Wang, CH Ding, SJ Lei, JP Liu, C Yin, PF Hu, J Ding, ... Cancer research 78 (16), 4680-4691, 2018 | 77 | 2018 |
| Co-delivery of docetaxel and salinomycin to target both breast cancer cells and stem cells by PLGA/TPGS nanoparticles J Gao, J Liu, F Xie, Y Lu, C Yin, X Shen International journal of nanomedicine, 9199-9216, 2019 | 72 | 2019 |
| Inhibition of extracellular signal‐regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats W Zhong, WF Shen, BF Ning, PF Hu, Y Lin, HY Yue, C Yin, JL Hou, ... Hepatology 50 (5), 1524-1536, 2009 | 71 | 2009 |
| The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1 CH Ding, C Yin, SJ Chen, LZ Wen, K Ding, SJ Lei, JP Liu, J Wang, ... Molecular cancer 17, 1-14, 2018 | 70 | 2018 |
| Co-delivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cells LY Gong Z, Chen D, Xie F, Liu J, Zhang H, Zou H, Yu Y, Chen Y, Sun Z, Wang X ... Nanomedicine (Lond), 2016 | 53* | 2016 |
| CD20 antibody-conjugated immunoliposomes for targeted chemotherapy of melanoma cancer initiating cells H Song, X Su, K Yang, F Niu, J Li, J Song, H Chen, B Li, W Li, W Qian, ... Journal of Biomedical Nanotechnology 11 (11), 1927-1946, 2015 | 46 | 2015 |
| Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate … D Chen, X Pan, F Xie, Y Lu, H Zou, C Yin, Y Zhang, J Gao International Journal of Nanomedicine, 6855-6870, 2018 | 39 | 2018 |
| Cationic liposomes induce cell necrosis through lysosomal dysfunction and late stage autophagic flux inhibition GJ Yang K, Lu Y, Xie F, Zou H, Fan X, Li B, Li W, Zhang W, Mei L, Feng SS ... Nanomedicine (Lond), 2016 | 38* | 2016 |
| Deletion of HNF1α in hepatocytes results in fatty liver‐related hepatocellular carcinoma in mice Q Ni, K Ding, KQ Wang, J He, C Yin, J Shi, X Zhang, WF Xie, YQ Shi FEBS letters 591 (13), 1947-1957, 2017 | 36 | 2017 |
| Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance X Su, H Song, F Niu, K Yang, G Kou, X Wang, H Chen, W Li, S Guo, J Li, ... Nanomedicine 10 (13), 2033-2050, 2015 | 35 | 2015 |
| Rifaximin ameliorates non-alcoholic steatohepatitis in mice through regulating gut microbiome-related bile acids J Jian, MT Nie, B Xiang, H Qian, C Yin, X Zhang, M Zhang, X Zhu, WF Xie Frontiers in pharmacology 13, 841132, 2022 | 30 | 2022 |
